Increased Expression of IL-1β Converting Enzyme in Hippocampus after Ischemia: Selective Localization in Microglia

Although the interleukin-1β converting enzyme (ICE)/CED-3 family of proteases has been implicated recently in neuronal cell deathin vitro and in ovo, the role of specific genes belonging to this family in cell death in the nervous system remains unknown. To address this question, we examined the in vivoexpression of one of these genes, Ice, after global forebrain ischemia in gerbils. Using RT-PCR and Western immunoblot techniques, we detected an increase in the mRNA and protein expression of ICE in hippocampus during a period of 4 d after ischemia. Chromatin condensation was observed in CA1 neurons within 2 d after ischemia. Internucleosomal DNA fragmentation and apoptotic bodies were observed between 3 and 4 d after ischemia, a period during which CA1 neuronal death is maximal. In nonischemic brains, ICE-like immunoreactivity was relatively low in CA1 pyramidal neurons but high in scattered hippocampal interneurons. After ischemia, ICE-like immunoreactivity was not altered in these neurons. ICE-like immunoreactivity, however, was observed in microglial cells in the regions adjacent to the CA1 layer as early as 2 d after ischemic insult. The increase in ICE-like immunoreactivity was robust at 4 d after ischemia, a period that correlates with the DNA fragmentation observed in hippocampal homogenates of ischemic brains. These results provide the first evidence for the localization and induction of ICE expression in vivo after ischemia and suggest an indirect role for ICE in ischemic damage through mediation of an inflammatory response.

[1]  P. Caron,et al.  Identification and Characterization of CPP32/Mch2 Homolog 1, a Novel Cysteine Protease Similar to CPP32 (*) , 1996, The Journal of Biological Chemistry.

[2]  A. Chinnaiyan,et al.  ICE-LAP3, a Novel Mammalian Homologue of the Caenorhabditis elegans Cell Death Protein Ced-3 Is Activated during Fas- and Tumor Necrosis Factor-induced Apoptosis (*) , 1996, The Journal of Biological Chemistry.

[3]  E. Alnemri,et al.  Mch3, a novel human apoptotic cysteine protease highly related to CPP32. , 1995, Cancer research.

[4]  Seamus J. Martin,et al.  Protease activation during apoptosis: Death by a thousand cuts? , 1995, Cell.

[5]  R. Oppenheim,et al.  Peptide inhibitors of the ice protease family arrest programmed cell death of motoneurons in vivo and in vitro , 1995, Neuron.

[6]  K. Hossmann,et al.  Reactive microglia in cerebral ischaemia: an early mediator of tissue damage? , 1995, Neuropathology and applied neurobiology.

[7]  Patrick R. Griffin,et al.  Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis , 1995, Nature.

[8]  E. Alnemri,et al.  Mch2, a new member of the apoptotic Ced-3/Ice cysteine protease gene family. , 1995, Cancer research.

[9]  S. Molineaux,et al.  Molecular Cloning and Pro-apoptotic Activity of ICErelII and ICErelIII, Members of the ICE/CED-3 Family of Cysteine Proteases (*) , 1995, The Journal of Biological Chemistry.

[10]  Muneesh Tewari,et al.  Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase , 1995, Cell.

[11]  M. Su,et al.  A novel human protease similar to the interleukin‐1 beta converting enzyme induces apoptosis in transfected cells. , 1995, The EMBO journal.

[12]  M. Su,et al.  Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. , 1995, Science.

[13]  R. Kamen,et al.  Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock , 1995, Cell.

[14]  R. Dolle,et al.  Inhibition of mature IL-1 beta production in murine macrophages and a murine model of inflammation by WIN 67694, an inhibitor of IL-1 beta converting enzyme. , 1995, Journal of immunology.

[15]  Y. Uchiyama,et al.  Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[16]  E. Alnemri,et al.  CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. , 1994, The Journal of biological chemistry.

[17]  K. Schulze-Osthoff,et al.  Cell nucleus and DNA fragmentation are not required for apoptosis , 1994, The Journal of cell biology.

[18]  Y. Lazebnik,et al.  Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE , 1994, Nature.

[19]  Douglas K. Miller,et al.  IL-1 beta-converting enzyme is present in monocytic cells as an inactive 45-kDa precursor. , 1994, Journal of immunology.

[20]  L. Wang,et al.  Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death , 1994, Cell.

[21]  T. Komiyama,et al.  Inhibition of interleukin-1 beta converting enzyme by the cowpox virus serpin CrmA. An example of cross-class inhibition. , 1994, The Journal of biological chemistry.

[22]  Mark A. Murcko,et al.  Structure and mechanism of interleukin-lβ converting enzyme , 1994, Nature.

[23]  M. Fishman,et al.  Prevention of vertebrate neuronal death by the crmA gene. , 1994, Science.

[24]  D. Giulian,et al.  Inflammatory glia mediate delayed neuronal damage after ischemia in the central nervous system. , 1993, Stroke.

[25]  Junying Yuan,et al.  Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3 , 1993, Cell.

[26]  Shai Shaham,et al.  The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme , 1993, Cell.

[27]  C. Dinarello.  Modalities for reducing interleukin 1 activity in disease. , 1993, Trends in pharmacological sciences.

[28]  D W Dickson,et al.  Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. , 1993, Journal of immunology.

[29]  D. Giulian,et al.  Brain glia release factors with opposing actions upon neuronal survival , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[30]  X. M. Sun,et al.  Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. , 1992, The Biochemical journal.

[31]  Y. Yamasaki,et al.  Possible involvement of interleukin-1 in ischemic brain edema formation , 1992, Neuroscience Letters.

[32]  J. Relton,et al.  Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat , 1992, Brain Research Bulletin.

[33]  S. Kumar,et al.  Identification of a set of genes with developmentally down-regulated expression in the mouse brain. , 1992, Biochemical and biophysical research communications.

[34]  K. O. Elliston,et al.  A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes , 1992, Nature.

[35]  C. March,et al.  Molecular cloning of the interleukin-1 beta converting enzyme. , 1992, Science.

[36]  M. Satoh,et al.  Induction of Interleukin‐1β mRNA in Rat Brain After Transient Forebrain Ischemia , 1992 .

[37]  J. Weidner,et al.  IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1 beta precursor at two distinct sites and does not cleave 31-kDa IL-1 alpha. , 1991, Journal of immunology.

[38]  C. Théry,et al.  Cytotoxic Effect of Brain Macrophages on Developing Neurons , 1991, The European journal of neuroscience.

[39]  C. Dinarello.  Interleukin-1 and interleukin-1 antagonism. , 1991, Blood.

[40]  W. Scheld,et al.  Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. , 1991, The Journal of clinical investigation.

[41]  C. Dinarello,et al.  Interleukin-1 augments gamma-aminobutyric acidA receptor function in brain. , 1991, Molecular pharmacology.

[42]  K. Goto,et al.  Effects of cycloheximide on delayed neuronal death in rat hippocampus , 1990, Brain Research.

[43]  L. Platanias,et al.  Interleukin-1: biology, pathophysiology, and clinical prospects. , 1990, The American journal of medicine.

[44]  R. Oppenheim,et al.  Naturally occurring and induced neuronal death in the chick embryo in vivo requires protein and RNA synthesis: evidence for the role of cell death genes. , 1990, Developmental biology.

[45]  D. P. Martin,et al.  Why do neurons die when deprived of trophic factor? , 1989, Neurobiology of Aging.

[46]  P. Distefano,et al.  Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation , 1988, The Journal of cell biology.

[47]  C. Colton,et al.  Production of superoxide anions by a CNS macrophage, the microglia , 1987, FEBS letters.

[48]  H. Horvitz,et al.  Genetic control of programmed cell death in the nematode C. elegans , 1986, Cell.

[49]  H. Killackey.  Glia and the elimination of transient cortical projections , 1984, Trends in Neurosciences.

[50]  J. Tata,et al.  Requirement for RNA and protein synthesis for induced regression of the tadpole tail in organ culture. , 1966, Developmental biology.

[51]  T. Deckwerth,et al.  Molecular mechanisms of developmental neuronal death. , 1993, Annual review of neuroscience.

[52]  D. Giulian.  Ameboid microglia as effectors of inflammation in the central nervous system , 1987, Journal of neuroscience research.